Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Bruns

Showing results (41-50 of 123) with videos related to

Pageof 13
Sort By:
Plos One|November 28, 2017
Generation Y and surgical residency - Passing the baton or the end of the world as we know it? Results from a survey among medical students in GermanyRobert Kleinert, Claudia Fuchs, Vanessa Romotzky, et al.
British Journal of Cancer|October 16, 2015
Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinomaSteffen Ormanns, Annelore Altendorf-Hofmann, Rene Jackstadt, et al.
Frontiers in Oncology|December 4, 2023
Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinomaVerena Maria Raters, Florian Gebauer, Heike Löser, et al.
Langenbeck'S Archives of Surgery|November 11, 2016
Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational databaseBenjamin Garlipp, Henry Ptok, Frank Benedix, et al.
Plos One|March 6, 2013
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgeryEike Gallmeier, Dominik C Bader, Lydia Kriegl, et al.
The International Journal of Developmental Biology|July 7, 2011
Cancer stem cells and angiogenesisYue Zhao, Qi Bao, Andrea Renner, et al.
European Journal of Radiology|December 10, 2020
Value of spectral detector CT for pretherapeutic, locoregional assessment of esophageal cancerDavid Zopfs, Nils Große Hokamp, Robert Reimer, et al.
Therapeutic Advances in Medical Oncology|June 18, 2020
Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategiesValeska Moentenich, Erdem Comut, Florian Gebauer, et al.
Scientific Reports|December 1, 2022
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinomaAlexander I Damanakis, Isabell Wahler, Hans Fuchs, et al.
Oncology Letters|May 12, 2020
Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategiesValeska Moentenich, Florian Gebauer, Erdem Comut, et al.
Pageof 13

Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Plos One|November 28, 2017
Generation Y and surgical residency - Passing the baton or the end of the world as we know it? Results from a survey among medical students in GermanyRobert Kleinert, Claudia Fuchs, Vanessa Romotzky, et al.
British Journal of Cancer|October 16, 2015
Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinomaSteffen Ormanns, Annelore Altendorf-Hofmann, Rene Jackstadt, et al.
Frontiers in Oncology|December 4, 2023
Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinomaVerena Maria Raters, Florian Gebauer, Heike Löser, et al.
Langenbeck'S Archives of Surgery|November 11, 2016
Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational databaseBenjamin Garlipp, Henry Ptok, Frank Benedix, et al.
Plos One|March 6, 2013
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgeryEike Gallmeier, Dominik C Bader, Lydia Kriegl, et al.
The International Journal of Developmental Biology|July 7, 2011
Cancer stem cells and angiogenesisYue Zhao, Qi Bao, Andrea Renner, et al.
European Journal of Radiology|December 10, 2020
Value of spectral detector CT for pretherapeutic, locoregional assessment of esophageal cancerDavid Zopfs, Nils Große Hokamp, Robert Reimer, et al.
Therapeutic Advances in Medical Oncology|June 18, 2020
Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategiesValeska Moentenich, Erdem Comut, Florian Gebauer, et al.
Scientific Reports|December 1, 2022
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinomaAlexander I Damanakis, Isabell Wahler, Hans Fuchs, et al.
Oncology Letters|May 12, 2020
Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategiesValeska Moentenich, Florian Gebauer, Erdem Comut, et al.
Pageof 13